Increased arginase levels contribute to impaired perfusion after cardiopulmonary resuscitation

European Journal of Clinical Investigation

Volumn 44, Issue 10, 2014, Pages 965-971

  Jung, Christian ^a,b   Quitter, Felix ^b   Lichtenauer, Michael ^b   Fritzenwanger, Michael ^b   Pfeil, Alexander ^b   Shemyakin, Alexey ^a   Franz, Marcus ^b   Figulla, Hans R ^b   Pfeifer, Ruediger ^b   Pernow, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Arginase; Heart failure; Intravital microscopy; Microcirculation; Sidestream darkfield

Indexed keywords

ARGINASE; ARGINASE I, HUMAN; ARGININE; ENZYME INHIBITOR; N(G) METHYLARGININE; N(OMEGA)-HYDROXYNORARGININE; NITRIC OXIDE;

ADULT; ANALOGS AND DERIVATIVES; ANOXIA; CAPILLARY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; HEART ARREST; HUMAN; MALE; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RESUSCITATION;

ADULT; ANOXIA; ARGINASE; ARGININE; CAPILLARIES; CARDIOPULMONARY RESUSCITATION; ENZYME INHIBITORS; FEMALE; HEART ARREST; HUMANS; MALE; MICROCIRCULATION; NITRIC OXIDE; OMEGA-N-METHYLARGININE;

EID: 84908660300     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12330     Document Type: Article

References (34)

1. Pfeifer R, Jung C, Purle S, Lauten A, Yilmaz A, Surber R et al. Survival does not improve when therapeutic hypothermia is added to post-cardiac arrest care. Resuscitation 2011;82:1168-73.
2. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 2002;288:3035-8.
3. De Backer D, Creteur J, Dubois M-J, Sakr Y, Vincent J-L. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91-9.
4. Jung C, Rodiger C, Fritzenwanger M, Schumm J, Lauten A, Figulla HR et al. Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol 2009;98:469-75.
5. den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Cheng JM, Spronk PE et al. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2010;31:3032-9.
6. Jung C, Ferrari M, Rodiger C, Fritzenwanger M, Figulla HR. Combined Impella and intra-aortic balloon pump support to improve macro- and microcirculation: a clinical case. Clin Res Cardiol 2008;97:849-50.
7. Jung C, Ferrari M, Roediger C, Fritzenwanger M, Goebel B, Lauten A et al. Evaluation of the sublingual microcirculation in cardiogenic shock. Clin Hemorheol Microcirc 2009;42:141-8.
8. Jung C, Lauten A, Ferrari M. Microcirculation in cardiogenic shock: from scientific bystander to therapy target. Crit Care 2010;14:193.
9. Omar YG, Massey M, Andersen LW, Giberson TA, Berg K, Cocchi MN et al. Sublingual microcirculation is impaired in post-cardiac arrest patients. Resuscitation 2013;84:1717-22.
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-4.
11. Parodi O, De Maria R, Roubina E. Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate-thiol interaction. J Cardiovasc Med 2007;8:765-74.
12. Visser M, Paulus WJ, Vermeulen MA, Richir MC, Davids M, Wisselink W et al. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 2010;12:1274-81.
13. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007;34:906-11.
14. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 2013;98:334-43.
15. Jung C, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 2010;85:147-54.
16. Gronros J, Jung C, Lundberg JO, Cerrato R, Ostenson CG, Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 2011;300:H1174-81.
17. Quitter F, Figulla HR, Ferrari M, Pernow J, Jung C. Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion. Clin Hemorheol Microcirc 2013;54:75-85.
18. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
19. Jung C, Ferrari M, Gradinger R, Fritzenwanger M, Pfeifer R, Schlosser M et al. Evaluation of the microcirculation during extracorporeal membrane-oxygenation. Clin Hemorheol Microcirc 2008;40:311-4.
20. den Uil CA, Caliskan K, Lagrand WK, van der Ent M, Jewbali LS, van Kuijk JP et al. Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. Intensive Care Med 2009;35:1893-9.
21. De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166:98-104.
22. Donadello K, Favory R, Salgado-Ribeiro D, Vincent JL, Gottin L, Scolletta S et al. Sublingual and muscular microcirculatory alterations after cardiac arrest: a pilot study. Resuscitation 2011;82:690-5.
23. van Genderen ME, Lima A, Akkerhuis M, Bakker J, van Bommel J. Persistent peripheral and microcirculatory perfusion alterations after out-of-hospital cardiac arrest are associated with poor survival. Crit Care Med 2012;40:2287-94.
24. Jung C, Figulla HR, Ferrari M. High frequency of organ failures during extracorporeal membrane oxygenation: is the microcirculation the answer? Ann Thorac Surg 2010;89:345-6.
25. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996;32:743-51.
26. Gando S, Kameue T, Nanzaki S, Igarashi M, Nakanishi Y. Platelet activation with massive formation of thromboxane A2 during and after cardiopulmonary resuscitation. Intensive Care Med 1997;23:71-6.
27. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997;77:278-82.
28. Krause BJ, Prieto CP, Munoz-Urrutia E, San Martin S, Sobrevia L, Casanello P. Role of arginase-2 and eNOS in the differential vascular reactivity and hypoxia-induced endothelial response in umbilical arteries and veins. Placenta 2012;33:360-6.
29. Gronros J, Kiss A, Palmer M, Jung C, Berkowitz D, Pernow J. Arginase inhibition improves coronary microvascular function and reduces infarct size following ischemia-reperfusion in a rat model. Acta Physiol (Oxf). 2013;208:172-9.
30. Klain GJ, Hannon JP. High altitude and protein metabolism in the rat. Proc Soc Exp Biol Med 1970;134:1000-4.
31. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004;30:2126-8.
32. Fries M, Tang W, Chang YT, Wang J, Castillo C, Weil MH. Microvascular blood flow during cardiopulmonary resuscitation is predictive of outcome. Resuscitation 2006;71:248-53.
33. Gonon AT, Jung C, Katz A, Westerblad H, Shemyakin A, Sjöquist P-O et al. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS ONE 2012;7:e42038.
34. Fritzenwanger M, Jung C, Goebel B, Lauten A, Figulla HR. Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells. Mediators Inflamm 2011;2011:429501.